Cordis buys into wound closure technology
This article was originally published in Clinica
Sunnyvale, California-based Ensure Medical's femoral artery wound closure technology is joining Cordis' expanding list of cardiovascular pipeline after it was acquired last week by the Johnson & Johnson subsidiary for an undisclosed sum.
You may also be interested in...
Biogen’s “recipe-driven qualification” knowledge management program standardizes data collection and reporting in the laboratory, with efficiency gains of 66%.
Less-invasive technologies to treat benign prostatic hyperplasia are fast becoming viable alternatives to medication and surgery. Landmark studies of newer techniques have led the American Urological Association to update its guidelines.